To study the effect of NS1 eIF4GI binding domain on virulence and pathogenicity of H5N1 influenza A virus, 5 recombinant H5N1 viruses encoding eIF4GI binding domain-truncated NS1 proteins and parental NS1 (NS1-wt) were generated by an 8-plasmid-based reverse genetics system. The results indicated that the recombinants with the addition of 5-amino acid and the deletion position of 85-89 in NS1-wt were attenuated in replication in vitro and in vivo, compared with the recombinant wild-type virus rNS1-wt, whereas the deletion position 85-94 or the entire eIF4GI binding domain in NS1-wt displayed a significantly attenuated phenotype in chicken and mice. We also showed that the eIF4GI binding domain-truncated mutants were impaired in their ability to inhibit interferon production in vitro, and they did not replicate as efficiently as the parental recombinant strain in embryonated hen eggs, in Madin -Darby Canine Kidney cells, or in vivo in chickens and in a mouse model. Therefore, these attenuated NS1-truncated viruses may have a great potential as live attenuated vaccine candidates against H5N1 influenza A virus.
M A J O R A R T I C L E
To study the effect of NS1 eIF4GI binding domain on virulence and pathogenicity of H5N1 influenza A virus, 5 recombinant H5N1 viruses encoding eIF4GI binding domain-truncated NS1 proteins and parental NS1 (NS1-wt) were generated by an 8-plasmid-based reverse genetics system. The results indicated that the recombinants with the addition of 5-amino acid and the deletion position of 85-89 in NS1-wt were attenuated in replication in vitro and in vivo, compared with the recombinant wild-type virus rNS1-wt, whereas the deletion position 85-94 or the entire eIF4GI binding domain in NS1-wt displayed a significantly attenuated phenotype in chicken and mice. We also showed that the eIF4GI binding domain-truncated mutants were impaired in their ability to inhibit interferon production in vitro, and they did not replicate as efficiently as the parental recombinant strain in embryonated hen eggs, in Madin -Darby Canine Kidney cells, or in vivo in chickens and in a mouse model. Therefore, these attenuated NS1-truncated viruses may have a great potential as live attenuated vaccine candidates against H5N1 influenza A virus.
Influenza A viruses are globally important human and animal respiratory pathogens that are responsible for both seasonal influenza outbreaks and periodic worldwide pandemics. Among the virus gene products, NS1 is the only nonstructural protein that accumulates in the nucleus early in the course of infection and in the nucleus and the cytoplasm later; it is also a multifunctional protein, of which at least 3 functional domains have been specified in this 230-amino acid protein: an RNA binding domain, an eIF4GI binding domain, and an effector domain. The amino-terminal 73 amino acids are responsible for binding to double-stranded RNAs [1] , conferring the ability to escape the alpha/beta interferon (IFN) response [2] . The eukaryotic translation initiation factor 4GI (eIF4GI) binding domain requires amino acids 81-113. Previous studies have suggested a model where NS1 recruits eIF4GI specifically to the 5 untranslated region of the viral messenger RNA (mRNA), allowing for the preferential translation of the influenza virus messengers [3, 4] . The NS1 effector domain, with a core sequence of amino acids 134-161 [5] , has been shown to inhibit host mRNA splicing [6] , polyadenylation [7, 8] , and binding to poly [A] tails of mRNA, preventing nuclear export [9] [10] [11] .
Widely regarded as a virulence factor, the NS1 RNA binding domain contributes significantly to disease pathogenesis by modulating many virus and host-cell processes, with down-regulation of host innate IFN-mediated antiviral responses during infection [12] [13] [14] , and the carboxy-terminal effector domain truncations of the NS1 protein of influenza A and B viruses, resulting in attenuation in mice [15, 16] . The viruses containing C-terminally truncated NS1 proteins of 73, 99, or 126 were found to induce more IFN than did viruses with full-length NS1 proteins [17] and were correspondingly more attenuated in mice and in pigs [18, 19] . All of these studies were largely performed with the RNA binding domain and the effector domain of the NS1 proteins, but little research has been conducted with regard to NS1 eIF4GI binding domain, and the biologic role of NS1 eIF4GI binding domain on the virulence and pathogenesis of H5N1 influenza virus has not yet been studied in detail.
In this study, we demonstrated that the NS1 eIF4GI binding domain was related to the virulence and pathogenicity of H5N1 influenza virus, that the NS1 eIF4GI binding domain-truncated mutants were attenuated in replication in vitro and in vivo, and that the level of attenuation correlated with the amounts of IFN-b induced by the respective NS1-truncated viruses.
MATERIALS AND METHODS

Viruses and plasmids.
Plasmids pHW-181-PB2, pHW-182-PB1, pHW-183-PA, pHW-185-NP, and pHW-187-M contain the corresponding genes of A/WSN/33 (H1N1). The H5N1 virus A/chicken/Hubei/327/2004 (CKDW/04) was isolated in central China during the outbreak of the highly pathogenic H5N1 avian influenza virus (AIV) in the spring of 2004. Pathogenesis tests in BALB/c mice and specific-pathogen free (SPF) chickens indicated that CKDW/04 was highly pathogenic to mice and had a chicken intravenous pathogenicity index (IVPI) of 3.0 [20] . The sequence accession numbers of HA, NA, and NS genes from CKDW/04 are AY684706, AY684708, and AY684710, respectively. Three plasmids-pHW-HA, pHW-NA, and pHW-NS-wt-contained HA, NA, and NS genes of CKDW/04, respectively, and other plasmids used to rescue NS mutants-pHW-NS1-SA5, pHW-NS1-SD5, pHW-NS1-SD10, and pHW-NS1-SD30-were derivatives of pHW-NS-wt by either deletion or insertion of nucleotides in the eIF4GI binding domain with use of oligonucleotide-directed mutagenesis. The recombinant viruses carried eIF4GI binding domain of different lengths ( Figure 1 ). All work with live H5N1 viruses was conducted in the ABSL-3 facilities at Huazhong Agricultural University (Wuhan, China).
Generation of recombinant viruses by reverse genetics. Each of 5 plasmids containing NS1 gene of different lengths from CKDW/04 (H5N1) (pHW-NS1-SA5, pHW-NS-wt, pHW-NS1-SD5, pHW-NS1-SD10, and pHW-NS1-SD30) was transfected with the 7 plasmids (pHW-181-PB2, pHW-182-PB1, pHW-183-PA, pHW-185-NP, and pHW-187-M) from A/WSN/33 (H1N1) and pHW-HA and pHW-NA from CKDW/04 (H5N1). Five recombinant H5N1 viruses-rNS1-SA5, rNS1-wt, rNS1-SD5, rNS1-SD10, and rNS1-SD30-were generated by an 8-plasmidbased reverse genetics system, as described previously [21, 22] .
Virus plaque assay. As described elsewhere [23] , for plaque assays, confluent Madin-Darby Canine Kidney (MDCK) cells in 6-well plates were inoculated with appropriate dilutions of virus in Dulbecco's Modified Eagle Medium (DMEM) containing 1% bovine serum albumin for 1 h at 37ЊC. Unbound virus was removed by washing with phosphate buffered saline (PBS). Cells were then overlaid with DMEM (without phenol red; HyClone) Ϫ0.8% agarose mixture and incubated at 37ЊC. After 3 days, a second agar overlay containing 1:10,000 neutral red was added to facilitate plaque counting. Each test was repeated 3 times.
Viral growth kinetics. To analyze viral replication, a comparison of viral growth kinetics for the recombinant wild-type and the 4 NS1 mutant viruses was undertaken in MDCK cells and Vero cells. Confluent MDCK cells or Vero cells were infected with each of the viruses at a multiplicity of infection of 0.01. Infected cells were maintained in DMEM containing 0.3% bovine serum albumin, 1% penicillin-streptomycin, and 1 mg/ mL L-1-tistkanudi-2-phenylethyl chloromethyl ketone-trypsin. The viral titer in the supernatant of infected cells was examined at 24, 48, and 72 h after infection by virus plaque assay, as described elsewhere [23] , and each test was repeated 3 times. Titers were expressed as log 10 plaque-forming units (PFU) per mL.
Mean death time (MDT) and 50% egg infectious dose (EID 50 ) in chicken embryos. The virulence of the 5 recombinant viruses was determined by the MDT and EID 50 in embryonated SPF chicken eggs. The MDT recorded was the mean time (in hours) required for the minimum lethal dose to kill the embryos, and the EID 50 was calculated by the method of Reed and Muench [24] .
Pathogenesis studies in chickens. Groups of 10 six-weekold SPF White Leghorn chickens were used in the chicken IVPI test with the recombinant viruses. In brief, chickens were inoculated intravenously with 0.2 mL of a 1:10 dilution of allantoic fluid containing the recombinant viruses and were ob- served clinically for 10 days, and IVPI was determined by Office International Des Epizooties (OIE) standard procedure. Additional pathogenesis tests were also conducted in chickens for mortality and for virus shedding. Groups of 10 six-week-old SPF chickens were also inoculated intravenously with the recombinant viruses at a dose of 10 6 EID 50 . Mortality was observed for 10 days, and viruses shed in the cloacal swab samples obtained on day 3 after infection were titrated by plaque assay in MDCK cells.
Pathogenesis studies in mice. As described elsewhere [25] , 6-week-old female BALB/c mice were anesthetized with methoxyflurane, and 50 mL of infectious viruses diluted in PBS were inoculated intranasally. The 50% mouse lethal dose (MLD 50 ) titers were determined by inoculating groups of 4 mice intranasally with serial 10-fold dilutions of virus, were calculated by the method of Reed and Muench [24] , and were expressed as the log 10 EID 50 required to give 1 MLD 50 . For comparison of morbidity (measured by weight loss), mortality, and virus distribution in different tissues, additional mice were infected with inoculating doses of 1000 EID 50 of the recombinant viruses. Mice were observed daily for 14 days for weight loss and mortality. On days 3, 6, 9, and 12 after infection, 3 mice from each group were sacrificed, and heart, liver, spleen, lung, kidney, brain, and rectum samples were harvested. Virus titers in the tissue homogenates were determined by plaque assay in MDCK cells. The virus titer in the tissue was expressed in log 10 PFU/ g. The lower limit of virus detection was 2 log 10 PFU per 1 g of tissue.
Measurement of IFN-b mRNA by real-time quantitative reverse-transcription polymerase chain reaction (RT-PCR).
MDCK cells were infected with 5 recombinant virus strains (rNS1-SA5, rNS1-wt, rNS1-SD5, rNS1-SD10, and rNS1-SD30) at a multiplicity of infection of 1 PFU/cell. At 24 h after infection at 37ЊC, the cells were collected, and total RNA was extracted using TRIzol (Invitrogen). Complementary DNA (cDNA) was synthesized with the Reverse Transcriptase XL (TaKaRa) and oligo dT primer (Toyobo). Each cDNA sample was used as a template for a real-time PCR amplification with reaction mixture containing SYBR Green I (Toyobo), forward and reverse primers for b-actin (forward primer: 5 CGA GAC ATT CAA CAC CCC AAC 3 ; reverse primer: 5 AGC CAG GTC CAG ACG CAA G 3 ) (internal control) or IFN-b (forward primer: 5 CGC CGC AAG GAC AGG ATA 3 ; reverse: 5 ACG GGA GGT TCA CAA GAA GGT T 3 ). All reactions were performed in triplicate, and an ABI PRISM 7500 sequence detection system was used for amplification and detection. The fold-changes were calculated as previously described by Livak and Schmittgen [26] . Data are mean values ‫ע(‬ standard deviation [SD]) of triplicate reactions for IFN-b gene transcript.
RESULTS
The generation and characterization of influenza viruses containing different NS1 mutants. With use of the PB2, PB1, PA, NP, and M from the mouse-adapted A/WSN/33 strain and the HA, NA, and NS from a highly pathogenic avian isolated strain, A/chicken/Hubei/327/2004/H5N1, as genetic backbone, the different deletions of NS1 were altered by applying reverse genetics. Five recombinant H5N1 viruses were generated (rNS1-SA5, rNS1-wt, rNS1-SD5, rNS1-SD10, and rNS1-SD30) ( Figure  1 ), all the recombinant viruses were sequenced, and no additional mutations were introduced.
As shown in Table 1 , rNS1-wt had a highest EID 50 , which was approximately 2-fold higher than rNS-SA5 or rNS-SD5. The EID 50 of rNS-SD10 and rNS-SD30 were 32-fold to 63-fold lower than rNS1-wt. For virus titers on chicken embryos (HA [log 2 ]) and MDCK cells (PFU), the recombinant wild-type virus rNS1-wt showed a slightly higher level than did rNS-SA5 and rNS-SD5. However, the virus titers of rNS-SD10 and rNS-SD30 showed a significantly lower level than did the virus titer of rNS1-wt. Compared with rNS1-wt, the MDT of rNS-SA5 and rNS-SD5 on chicken embryos showed 4-6-h delay. Importantly, rNS-SD10 and rNS-SD30 were significantly attenuated to chicken embryos and showed a 28-38-h delay on MDT, compared with rNS1-wt. For the plaque on MDCK cells, the recombinant wild-type virus rNS1-wt exhibited larger plaque size, compared with that displayed by the other NS1 mutant viruses, and rNS-SD10 and rNS-SD30 displayed a small plaque size (!1 mm).
Viral replication in MDCK cells and vero cells. Growth of the recombinant wild-type and the 4 NS1 mutant viruses was examined in MDCK cells and Vero cells. Growth in the supernatant of infected cells was examined at 24, 48, and 72 h after infection by virus plaque assay. The recombinant wildtype virus rNS1-wt replicated to the highest titers in MDCK cells, with rNS1-SA5 and rNS1-SD5 reaching slightly lower virus titers (Figure 2A ). The rNS1-SD10 and rNS1-SD30 were severely attenuated in their replication and replicated at significantly lower virus titers than did the recombinant wild-type virus rNS1-wt ( ) (Figure 2A ). However, in IFN-deficient P ! .01 Vero cells, all of the recombinant viruses replicated to high titers, comparable to those for the recombinant wild-type virus rNS1-wt, and there was no significant difference with respect to virus titers among these recombinant viruses ( ) (Fig-P 1 .05 ure 2B).
Pathogenesis studies of recombinant viruses in chickens. According to the criteria set by OIE for evaluating pathogenesis in chickens, the virus with an IVPI value 11.2 is defined as highly pathogenic avian influenza virus (HPAIV). As expected, rNS1-wt belonged to HPAIV, whereas rNS1-SA5 and rNS1-SD5, with values of 0.87 and 0.43, respectively, were low pathogenic avian influenza viruses (LPAIV). It was found that the rNS1-SD10 and rNS1-SD30 did not cause any disease signs or deaths in chicken.
Additional pathogenesis tests were also conducted in chickens. Groups of 10 4-week-old SPF chickens were inoculated intravenously with the recombinant viruses at a dose of 10 6 EID 50 . The mortality and virus shedding tests in chickens indicated that rNS1-wt caused more deaths (4 of 10) and viral shedding from cloaca than did rNS1-SA5 and rNS1-SD5 ( Table  1 ). The rNS1-SD10 and rNS1-SD30 did not cause any disease signs or death in chickens, and virus shedding was not detected. Table 1 , MLD 50 of rNS1-SA5, rNS1-SD5, rNS1-SD10, and rNS1-SD30 were respectively 2.1-fold, 2.6-fold, 12.6-fold, and 158.5-fold higher than that of rNA-wt.
For comparison of morbidity (measured by weight loss) and mortality, additional mice were inoculated intranasally with 1000 EID 50 of the recombinant viruses. The body weight of each mouse was measured daily until 14 days after infection. All mice infected with any of the recombinant viruses had experienced extensive body weight loss, with rNS1-SA5 and rNS1-SD5 causing great weight loss and rNS1-wt caused the greatest weight loss ( Figure 3A) . The rNS1-SD10 and rNS1-SD30 viruses caused significantly lower weight loss than did rNS1-wt ( ). P ! .001 The rNS1-wt caused rapid death in mice beginning with the fifth day after infection, and all of the mice in the virus group were found dead within 8 days after infection. However, mice infected with rNS1-SA5 or rNS1-SD5 experienced a 1-to 3-day delay in death, compared with mice infected with rNS1-wt, and all mice except group rNS1-SD10 and group rNS1-SD30 mice succumbed to infection by day 11 after infection ( Figure 3B ). In contrast to the lethal outcome in mice infected with rNS1-wt, mice infected with rNS1-SD10 and rNS1-SD30 had 50% and 100% survival, respectively, at 14 days after infection, which indicated that the virus was significantly attenuated ( Figure 3B ).
The distribution of the recombinant viruses in mouse tissue is presented in Figure 4 . The virus was recovered from a variety of organs of the mice infected with the recombinant viruses, including heart, liver, spleen, lung, kidney, brain, and rectum.
As shown in Figure 4 , the rNS1-wt replicated to higher titers in all tissues than did rNS1-SA5, rNS1-SD5, and rNS1-SD10, which indicated that rNS1-SA5, rNS1-SD5, and rNS1-SD10 displayed an attenuated phenotype in mice. The rNS1-SD10 and rNS1-SD30 showed significantly lower titers than did rNS1-wt ( ). The rNS1-SD30 was dramatically attenuated in P ! .01 mice and did not cause any systemic infection, and the virus could not be recovered from the liver, spleen, kidney, and brain of infected mice.
Quantification of IFN mRNA synthesis by real-time RT-PCR. To evaluate the ability of these NS1 reassortants to induce expression of IFN-b mRNA, relative quantification of the IFN-b gene transcript was examined by a real-time PCR ( Figure  5 ). The rNS1-SD30 appeared to induce the highest levels of IFN, followed by the rNS1-SD10, rNS1-SD5, and rNS1-SA5 mutant viruses. The levels of IFN-b mRNA induced by the recombinant wild-type virus rNS1-wt were approximately 100-fold lower than those induced by the rNS1-SD30 ( ). P ! .001
DISCUSSION
Since 2000, an increasing number of HPAI H5N1 viruses have been shown to possess a 15-nucleotide deletion at nucleotide positions 263-277 of the NS gene (amino acid positions 80-84 of NS1) [27] [28] [29] . Deletion of 5 amino acids from positions 80-84 in the NS1 of H5N1 viruses has been an intriguing trend in H5N1 viruses isolated. There was an increase in the percentage of H5N1 isolates containing the deleted NS from 2000 (25%) to 2007 (100%) (unpublished data). It has been indicated that the 5-amino acid deletion in the NS1 protein contributed to the increase in virulence of H5N1 viruses in chickens and mice [30] . In this study, rNS1-SA5-the recombinant virus Figure 4 . The virus distribution of different tissues in mice infected with the recombinant viruses. Mice were infected with an inoculating dose of 1000 50% egg infectious dose (EID 50 ) of the recombinant viruses. On days 3, 6, 9, and 12 after infection, 3 mice from each group were sacrificed, and heart (A), liver (B ), spleen (C ), lung (D ), kidney (E ), brain (F ), and rectum (G ) samples were harvested. Virus titers in the tissue homogenates were determined by plaque assay in Madin-Darby Canine Kidney cells. The virus titer in the tissues was expressed in log 10 plaque-forming units [PFU] per g. The lower limit of virus detection was 2 log 10 PFU/g of tissue. The statistical analysis was performed using Student's t test.
with complete NS1, which is similar to the H5N1 virus detected before 2000-displayed an attenuated phenotype, compared with that of the recombinant 5-amino acid deletion virus rNS1-wt, which is similar to the H5N1 virus detected after 2000. The 5-amino acid deletion was in the region of the eIF4GI binding domain of the NS1 protein (81-113). The increased virulence and pathogenicity of H5N1 isolates with a 5-amino acid deletion may be associated with a changed length of the NS1 eIF4GI binding domain.
Earlier studies had shown that the substitution of aspartic acid (D) for glutamic acid (E) at position 92 of the NS1 protein of the H5N1 influenza virus that was transmitted to humans in 1997 was critical in conferring virulence and resistance to antiviral cytokines in pigs [31, 32] . Deletion of 5 amino acids (Figure 1 ). Compared with rNS1-SA5, the recombinant rNS1-SD5 containing 92 D exhibited an equivalent virus titer in chicken embryos and MDCK cells, and similar virulence and pathogenicity were exhibited in chicken and mice. However, both of the viruses displayed a delayed MDT in eggs; a lower IVPI, lower mortality, and less virus shedding in chickens; and higher MLD 50 and lower virus titers of tissues in infected mice than did the recombinant wild-type virus rNS1-wt. In comparison with the recombinant wild-type virus rNS1-wt, the recombinant rNS1-SD5 displayed a slightly attenuated phenotype in chicken and mice. However, when the deletion that included 92 D in NS1 was performed, the recombinant rNS1-SD10 replicated to a significantly lower virus titer in chicken embryos and MDCK cells and was significantly attenuated in chicken and mice, compared with the recombinant wild-type virus rNS1-wt. The recombinant rNS1-SD10 did not cause any disease signs or deaths in chicken ( ) but still caused IVPI p 0 systemic infection in mice similar to that caused by rNS1-wt.
When the NS1 eIF4GI binding domain was deleted completely, the recombinant rNS1-SD30 was still viable and replicated efficiently in chicken embryos and MDCK cells, although it displayed a highly attenuated phenotype, compared with that of rNS1-wt. The rNS1-SD30 did not cause any disease signs or deaths in chicken ( ), and the virus shed-IVPI p 0 ding was not recovered. It was also highly attenuated and did not cause systemic infection in mice, with the lowest replication and the most-rapid tissue virus clearance. The replication and attenuating properties of rNS1-SD30 suggested its potential use in the development of live influenza virus vaccine candidate strains.
Previous work has demonstrated that NS1 protein interacts directly and specifically with eIF4GI factor in vitro and that they associate in vivo during influenza virus infection in what appears to be a feature common to other viruses to improve virus translation [33] . In this study, the different deletions of the eIF4GI binding region may affect the binding ability of NS1 protein and eIF4GI factor, resulting in the degradation of the initial rate of viral mRNA translation. On the other hand, because of the multifunctional nature of NS1 and the fact that the eIF4GI binding region overlaps with hStaufen and CPSF30, the deletion of the eIF4GI binding region may also affect the interactions of NS1 with hStaufen or CPSF30 and cause severe attenuation of the virus.
One of the well-determined functions of the NS1 protein is its ability to antagonize a/b IFN-induced antiviral response. The NS1 protein of influenza A virus binds to double-stranded RNA (dsRNA), interacts with putative cellular kinase(s), and prevents the activation of IFN-inducible dsRNA-activated kinase [34] [35] [36] . This results in the NS1 protein inhibiting the expression of INF-a/b genes and prevents the formation of the antiviral state in neighboring cells [37] . These properties have been mapped to the amino-terminal domain of the NS1 protein [38] , and the carboxy-terminal domain of the NS1 also contributes to its IFN-antagonistic properties [39] . However, the effect of NS1 eIF4GI binding domain of H5N1 influenza virus on a/b IFN-induced antiviral response has not yet been studied in detail. Earlier studies with recombinant influenza A virus carrying deletions in the NS1 gene showed a strong attenuation in IFN-competent systems, whereas the NS1-deleted virus replicated to levels similar to those of wild-type virus in cell culture and in mice with a defect in the IFN system [13, 15, 40] . In this study, several influenza NS1 mutants containing the truncation of eIF4GI binding domain were examined for their growth ability in MDCK cells and IFN-deficient Vero cells. These truncated NS1 mutants showed impaired growth properties and impaired ability to inhibit IFN production in vitro, and they did not replicate as efficiently as the parental recombinant strain in IFN-competent MDCK cells but replicated as efficiently as the wild-type virus in IFN-deficient Vero cells. Therefore, this indicated that the deletion of NS1 eIG4GI binding domain resulted in increased production of IFN and reduced replication of virus in IFN-competent systems.
In summary, we have demonstrated here that the eIF4GI binding domain of NS1 plays an important role in the virulence and pathogenicity of H5N1 influenza A virus, that the NS1 eIF4GI binding domain-truncated mutants were attenuated in replication in vitro and in vivo, and that the level of attenuation correlated with the amounts of IFN-b induced by the respective NS1-truncated viruses. The deletion from positions 85-94 or of the entire eIF4GI binding domain in NS1 displayed a significantly attenuated phenotype in chicken and mice, implying that multiple domains within NS1 eIF4GI binding domain may be suitable targets for the development of antiviral drugs and attenuated vaccines.
